Publication: Cholesterol lowering effects of a choleretic phloracetophenone in hypercholesterolemic hamsters
Issued Date
2002-03-29
Resource Type
ISSN
00142999
Other identifier(s)
2-s2.0-0037192580
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
European Journal of Pharmacology. Vol.439, No.1-3 (2002), 141-147
Suggested Citation
Pawinee Piyachaturawat, Pornpikul Srivoraphan, Aporn Chuncharunee, Prayad Komaratat, Apichart Suksamrarn Cholesterol lowering effects of a choleretic phloracetophenone in hypercholesterolemic hamsters. European Journal of Pharmacology. Vol.439, No.1-3 (2002), 141-147. doi:10.1016/S0014-2999(02)01453-X Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/20595
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cholesterol lowering effects of a choleretic phloracetophenone in hypercholesterolemic hamsters
Other Contributor(s)
Abstract
The plasma cholesterol-lowering effect and mechanism thereof of a choleretic phloracetophenone or 2,4,6-trihydroxyacetophenone (THA) were investigated in hypercholesterolemic male hamsters. Intragastric administration of THA (300-600 μmol/kg) twice a day for 7 days to these animals caused a dose- and time-dependent decrease in both plasma cholesterol and triglyceride levels. THA at a dose of 400 μmol/kg reduced the cholesterol and triglyceride levels in plasma to 52% and 25% of the level in corresponding cholesterol-fed controls, respectively, with decreases in both plasma very low density lipoprotein and low density lipoprotein cholesterol but not in high density lipoprotein cholesterol. THA did not significantly alter total hepatic cholesterol content but significantly increased the excretion of both bile acids and cholesterol into the intestinal lumen for elimination. Corresponding to the increase in bile acid excretion, THA caused a seven-fold increase in hepatic cholesterol 7α-hydroxylase activity. These results suggest that THA exerts its cholesterol lowering effect by increasing hepatic cholesterol 7α-hydroxylase activity which increases hepatic conversion of cholesterol to bile acid for disposal via biliary secretion. This compound may have a potential for future development as a therapeutic agent for lowering lipids in hypercholesterolemic patients. © 2002 Elsevier Science B.V. All rights reserved.